Continuous Glucose Monitoring (CGM) is a minimally invasive medical device that provides real-time monitoring of glucose levels in the body by analyzing interstitial fluid (ISF) levels. CGM systems consist of a sensor, transmitter, and receiver that continuously measure and transmit glucose data to a display device, allowing users to track their glucose levels throughout the day and night.
1. Improved Glycemic Control: CGM provides real-time insights into glucose trends and patterns, enabling individuals with diabetes to adjust their insulin doses and lifestyle accordingly, leading to better glycemic control and reduced HbA1c levels.
2. Increased Time in Range: CGM helps individuals stay within their target glucose range (70-180 mg/dL) for a longer duration, reducing the risk of hypoglycemia and hyperglycemia.
3. Early Detection of Hypoglycemia and Hyperglycemia: CGM provides alerts and alarms when glucose levels reach predefined thresholds, allowing individuals to promptly intervene and prevent severe events.
4. Better Sleep Quality: CGM eliminates the need for frequent fingerstick checks, allowing individuals to sleep more soundly without interruptions for blood glucose monitoring.
5. Reduced Healthcare Costs: By improving glycemic control and reducing complications, CGM can significantly reduce healthcare costs associated with diabetes management.
CGM Device | Manufacturer | Key Features |
---|---|---|
Dexcom G6 | Dexcom | Continuous monitoring with factory-calibrated sensor, alerts and alarms, glucose trends and reports |
FreeStyle Libre 2 | Abbott | Minimal pain insertion, 14-day sensor, real-time glucose readings |
Eversense E3 | Senseonics | Long-term implant sensor with up to 90-day usage, Bluetooth connectivity |
Guardian Connect | Medtronic | Advanced algorithms for personalized diabetes management, customizable alerts and reports |
The cost of CGM devices and supplies in Singapore can vary depending on the device and insurance coverage. Some government subsidies are available for eligible individuals:
Subsidy | Eligibility | Coverage |
---|---|---|
Medisave | Singapore citizens and permanent residents | Up to 75% subsidy for CGM sensor supplies, subject to a maximum of S$1,000 per year |
CHAS Orange | Singapore citizens with household income < S$1,800 per month | Up to 75% to 90% subsidy for CGM sensor supplies |
Consider the following factors when choosing a CGM device:
"Glucosystems" is an emerging field that explores novel applications of CGM technology beyond traditional diabetes management. These applications include:
Continuous Glucose Monitoring is a revolutionary tool that empowers individuals with diabetes to take control of their blood glucose levels, improve their health outcomes, and lead more fulfilling lives. With technological advancements and innovative applications, CGM is transforming diabetes management and paving the way for personalized and optimized healthcare.
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2025-01-05 01:37:20 UTC
2024-09-23 14:22:26 UTC
2024-09-20 13:03:11 UTC
2024-10-12 16:43:55 UTC
2024-09-28 11:20:46 UTC
2024-10-17 16:27:47 UTC
2024-12-24 07:20:39 UTC
2024-12-31 01:17:52 UTC
2025-01-08 06:15:39 UTC
2025-01-08 06:15:39 UTC
2025-01-08 06:15:36 UTC
2025-01-08 06:15:34 UTC
2025-01-08 06:15:33 UTC
2025-01-08 06:15:31 UTC
2025-01-08 06:15:31 UTC